Cargando…

Characterisation of COPD heterogeneity in the ECLIPSE cohort

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a complex condition with pulmonary and extra-pulmonary manifestations. This study describes the heterogeneity of COPD in a large and well characterised and controlled COPD cohort (ECLIPSE). METHODS: We studied 2164 clinically stable COPD pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agusti, Alvar, Calverley, Peter MA, Celli, Bartolome, Coxson, Harvey O, Edwards, Lisa D, Lomas, David A, MacNee, William, Miller, Bruce E, Rennard, Steve, Silverman, Edwin K, Tal-Singer, Ruth, Wouters, Emiel, Yates, Julie C, Vestbo, Jørgen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944278/ https://www.ncbi.nlm.nih.gov/pubmed/20831787 http://dx.doi.org/10.1186/1465-9921-11-122

Ejemplares similares

Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
por: Celli, Bartolome, et al.
Publicado: (2021)

Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
por: Agustí, Alvar, et al.
Publicado: (2012)

Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy
por: Martin, Mickaël, et al.
Publicado: (2017)

It’s more than low BMI: prevalence of cachexia and associated mortality in COPD
por: McDonald, Merry-Lynn N., et al.
Publicado: (2019)

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort
por: Dickens, Jennifer A, et al.
Publicado: (2011)

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
por: Singh, Dave, et al.
Publicado: (2010)

A Genome-wide analysis of the response to inhaled beta2-agonists in Chronic Obstructive Pulmonary Disease
por: Hardin, Megan, et al.
Publicado: (2015)

Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort
por: Singh, Dave, et al.
Publicado: (2014)

Natural history of COPD: gaps and opportunities
por: Agustí, Alvar, et al.
Publicado: (2017)

COPD: time to improve its taxonomy?
por: Celli, Bartolomé R., et al.
Publicado: (2018)

Specific elastin degradation products are associated with poor outcome in the ECLIPSE COPD cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD – results from the ECLIPSE study
por: Sand, Jannie M. B., et al.
Publicado: (2016)

Combining biomarkers of clot resolution and alveolar basement membrane destruction predicts mortality in the ECLIPSE COPD cohort
por: Sand, Jannie M.B., et al.
Publicado: (2020)

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change
por: Jones, Paul W, et al.
Publicado: (2011)

Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort
por: Rønnow, Sarah R., et al.
Publicado: (2020)

Heme metabolism genes Downregulated in COPD Cachexia
por: Wilson, Ava C., et al.
Publicado: (2020)

Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale
por: Al-shair, Khaled, et al.
Publicado: (2012)

Sexually-dimorphic targeting of functionally-related genes in COPD
por: Glass, Kimberly, et al.
Publicado: (2014)

Informe de la Barcelona-Boston Lung Conference 2021
por: Celli, Bartolomé, et al.
Publicado: (2021)

Opportunities and Challenges in the Genetics of COPD 2010: An International COPD Genetics Conference Report
por: Silverman, Edwin K, et al.
Publicado: (2011)

Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
por: Brook, Robert D, et al.
Publicado: (2017)

Low Liver Density Is Linked to Cardiovascular Comorbidity in COPD: An ECLIPSE Cohort Analysis
por: Viglino, Damien, et al.
Publicado: (2019)

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study
por: Celli, Bartolome, et al.
Publicado: (2017)

Influence of diet and obesity on COPD development and outcomes
por: Hanson, Corrine, et al.
Publicado: (2014)

A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease
por: Menche, Jörg, et al.
Publicado: (2014)

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial
por: Celli, Bartolome R, et al.
Publicado: (2019)

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
por: Agusti, Alvar, et al.
Publicado: (2023)

FEV(1) is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
por: Bikov, Andras, et al.
Publicado: (2020)

Associations between COPD related manifestations: a cross-sectional study
por: Romme, Elisabeth APM, et al.
Publicado: (2013)

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study
por: Jenkins, Christine R, et al.
Publicado: (2009)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

The severity of airways obstruction as a determinant of treatment response in COPD
por: Calverley, Peter MA, et al.
Publicado: (2006)

The EASI model: A first integrative computational approximation to the natural history of COPD
por: Agustí, Alvar, et al.
Publicado: (2017)

Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial
por: Brigham, Emily P., et al.
Publicado: (2021)

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
por: Celli, Bartolome R., et al.
Publicado: (2015)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Targeted treatment in COPD: a multi-system approach for a multi-system disease
por: Anderson, David, et al.
Publicado: (2009)

Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis
por: Faner, Rosa, et al.
Publicado: (2019)

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials
por: Calverley, Peter M. A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_25ms4p0h92fg7mdeff9q93jd63